Ophthalmology BD & In-Licensing Director

Evolve Selection; Birmingham; On-site; GBP 100,000 - 180,000; Full time

Benefits offered by this job

Bonus

Pension

Healthcare

Eye care vouchers

Wellbeing days

Career development

Job summary

Evolve is partnering with an ambitious eyecare business to appoint a Business Development & In-Licensing Director. Reporting to the CEO, you will shape and lead the business development function, build a pipeline of innovative assets and strategic partnerships, and drive high-value transactions from initial evaluation through to completion.

This permanent, full-time role covers the US, UK, and Ireland with significant autonomy to build the function from the ground up.

Qualifications

• PhD/MD or equivalent in ophthalmology or related field.
• 8+ years in pharma/biotech/medtech business development, licensing or corporate development with proven deal making.
• Strong ophthalmology network across biotech, academia, investors and clinicians.
• Commercial acumen with understanding of deal valuation and investments.
• Entrepreneurial leadership and willingness to travel ~30%.

Responsibilities

• Shape and lead the business development and in-licensing strategy.
• Build a pipeline of innovative assets, technologies and partnerships across eyecare.
• Lead scientific evaluation and investment decisions with commercial insight.
• Drive end-to-end deals: due diligence, structuring and negotiations.
• Represent the organization at industry events and establish it as a partner of choice.

Skills

Business development

Deal-making

Leadership

Networking

Strategic thinking

Presentation to leadership

Education

PhD or MD in ophthalmology or related field

MBA or business qualification

Job description

Evolve is partnering with an ambitious eyecare business to appoint a Business Development & In-Licensing Director. Reporting to the CEO, you will shape and lead the business development function, build a pipeline of innovative assets and strategic partnerships, and drive high-value transactions from initial evaluation through to completion.

This permanent, full-time role covers the US, UK, and Ireland with significant autonomy to build the function from the ground up.